# Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study

> **NCT02789982** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 364 (actual)

## Conditions studied

- Post-traumatic Stress Disorder

## Interventions

- **DRUG:** β-adrenergic blocker propranolol
- **BEHAVIORAL:** Treatment as usual

## Key facts

- **NCT ID:** NCT02789982
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-27
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2023-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789982, "Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02789982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*